Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!

類似資料

• Rationale for Effective Prophylaxis Against COVID‐19 Through Simultaneous Blockade of Both Endosomal and Non‐Endosomal SARS‐CoV‐2 Entry into Host Cell
  著者:: Nabavi, Seyed Fazel, 等
  出版事項: (2021)
• Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
  著者:: Habtemariam, Solomon, 等
  出版事項: (2020)
• Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series?
  著者:: Cismaru, Andrei Cosmin, 等
  出版事項: (2020)
• Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
  著者:: Nabavi, Seyed Fazel, 等
  出版事項: (2020)
• Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
  著者:: Dowran, Razieh, 等
  出版事項: (2020)